Navigation Links
Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
Date:5/5/2008

TORONTO, May 5 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP), a biopharmaceutical company dedicated in the research, development and commercialization of pharmaceutical products and technologies for the management of cancer, announced today that it has strengthened its senior management team with the appointment of Dr. Saeid Babaei to Vice-President of Business Development and Dr. Yoon Lee to Vice-President of Research. Both will serve as members of Lorus' senior management team.

Dr. Babaei joined Lorus in 2006, where he has held the progressive positions of Associate Director of Corporate Affairs and Director of Corporate Development, and has played a key role in a broad range of activities involving investor relations, business development and licensing strategies. As Vice-President of Business Development, Dr. Babaei will have responsibilities in planning, developing and implementing Lorus' business development efforts and strategic partnerships. His multi-disciplinary experience spans over fifteen years in the biotechnology and healthcare sectors, during which he has negotiated strategic alliances and licensing deals, established joint ventures and assisted in private financings to support product development. Dr. Babaei received a PhD and an executive MBA, both from the University of Toronto. He has authored many scientific publications, patents and conference proceedings. He currently serves as a member of the Board of Directors for several not-for-profit organizations.

Dr. Lee has been with Lorus for ten years, most recently serving as the Director of Research. He has been responsible for overseeing research discovery and product development programs, including anticancer immunomodulators, DNA/RNA-based therapeutics and small molecules. As Vice- President of Research, Dr. Lee will be responsible for developing and implementing the scientific direction of Lorus. Dr. Lee received his Ph.D. degree in Molecu
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
4. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
5. Lorus initiates development program exploring novel route of administration for LOR-2040
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...PRNewswire/ - Aegera Therapeutics Inc. announced t...ed Phase 2B study of AEG35156, a targeted antisens...e oncology indications. ,, The study, entitled ...inked Inhibitor of Apoptosis (XIAP) Antisense AEG3...e and Idarubicin in AML Following Failure of a Sin...
(Date:11/19/2009)...und is honored by latest award for revolutionary h...(PRWEB) November 16, 2009 -- Popular Science Magaz...aring aid from InSound Medical a winner of its cov...category.    Chosen from thous... in the hearing canal for up to four months while ...
(Date:11/18/2009)...stitute of Standards and Technology (NIST) has dem...for detecting and measuring elusive hazards such a...age in food or pesticides distributed in soil by w...ve than conventional techniques for detecting trac...olecules, having distinct electrically positive an...
(Date:11/18/2009)...sity Belfast are developing new sensors to detect ...in the fight against the threat of terrorist attac...swipe, an individual or crime scene to gather a sa...nt that can detect the presence of chemicals withi...s to be made in response to terrorist threats. ,...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Prototype NIST method detects and measures elusive hazards 2New technology detects chemical weapons in seconds 2
...C(R), a member of,the Sigma-Aldrich Group (Nasdaq:...om Beil as Vice President of Quality and Regulator...ality systems and operations professional with,nea...uality assurance team,and oversee all aspects of t...rams. He will report to SAFC President, Dr. Frank ...
... repurchase program and positive cash flow from ...ug. 4 AMICAS, Inc. (Nasdaq: AMCS ), a,leader in ...ment solutions,today reported unaudited financial ...., (Logo: http://www.newscom.com/cgi-bin/prnh... Revenue: Total revenues for the second quarter of...
...cord $35.5 million vs. $24.7 million in Q2 2007 ... 2008 Diluted Net Income per Share - $0.13 vs. $0....ase of 62.5% Q2 2008 Operating Income margin o...s of $49.0 million vs. $34.5 million in Q2 2007, ...T), (Nasdaq: ERES ), a leading provider of centra...
Other Biology Technology:SAFC Appoints New Vice President of Quality and Regulatory Affairs 2SAFC Appoints New Vice President of Quality and Regulatory Affairs 3AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 2AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 3AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 4AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 5AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 6AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 7AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 8AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 9AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 10AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 11AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008 12eResearchTechnology Reports Second Quarter 2008 Results 2eResearchTechnology Reports Second Quarter 2008 Results 3eResearchTechnology Reports Second Quarter 2008 Results 4eResearchTechnology Reports Second Quarter 2008 Results 5eResearchTechnology Reports Second Quarter 2008 Results 6eResearchTechnology Reports Second Quarter 2008 Results 7eResearchTechnology Reports Second Quarter 2008 Results 8eResearchTechnology Reports Second Quarter 2008 Results 9
(Date:11/20/2009)...., November 19, 2009 The estimated 4.6 million Am...risk of developing respiratory symptoms due to poo...ionnaire study undertaken earlier this year by inv...f Veterinary Medicine. , The studywhich polled m...at 50 percent of individuals working in barns comp...
(Date:11/20/2009)...9th 2009 - Bacteria possess an ingenious mechanism...locks of the cell. This is the new finding of a te...B, a life sciences research institute in Flanders,...sel. The scientists made this discovery by modifyi...a coli . By means of this model organism, they hav...
(Date:11/20/2009)... pulmonary disease (COPD), a respiratory disease c...is the fourth leading cause of death worldwide. 6...hers have yet to find any real treatment or cure, ... University of Western Ontario in London, Canada, ...sight into the disease. , Parraga is a scien...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Union Members Reject Key Tenets of 26quot 3BObamacare 26quot 3B According to Recent Zogby O 26apos 3BLeary Poll 58065 1Union Members Reject Key Tenets of 26quot 3BObamacare 26quot 3B According to Recent Zogby O 26apos 3BLeary Poll 58065 2Union Members Reject Key Tenets of 26quot 3BObamacare 26quot 3B According to Recent Zogby O 26apos 3BLeary Poll 58065 3Union Members Reject Key Tenets of 26quot 3BObamacare 26quot 3B According to Recent Zogby O 26apos 3BLeary Poll 58065 4Union Members Reject Key Tenets of 26quot 3BObamacare 26quot 3B According to Recent Zogby O 26apos 3BLeary Poll 58065 5Union Members Reject Key Tenets of 26quot 3BObamacare 26quot 3B According to Recent Zogby O 26apos 3BLeary Poll 58065 6Union Members Reject Key Tenets of 26quot 3BObamacare 26quot 3B According to Recent Zogby O 26apos 3BLeary Poll 58065 7VAs Health System Top Employer for AARP 58061 1VAs Health System Top Employer for AARP 58061 2American Red Cross Launches Ready Rating Program to Prepare Businesses and Schools for Emergencies in 16 U S Cities From Coast to Coast 58057 1American Red Cross Launches Ready Rating Program to Prepare Businesses and Schools for Emergencies in 16 U S Cities From Coast to Coast 58057 2American Red Cross Launches Ready Rating Program to Prepare Businesses and Schools for Emergencies in 16 U S Cities From Coast to Coast 58057 3American Red Cross Launches Ready Rating Program to Prepare Businesses and Schools for Emergencies in 16 U S Cities From Coast to Coast 58057 4
...Carl Marci Wins Gold Innovation Award; Senior Scie...rd; President Brian Levine Receives Certificate of...esearch (R), a revolutionary biometric media res...urement, has received three Great Minds Innovation..., , The Innovation Awards, which were presented l...
...ON, Ky. (April 6, 2009) The side effects of an ex...ently being investigated for a variety of diseases...ered, according to a study by a University of Kent...research published last year in the journal Nature...nd his colleagues found that the new drug modality...
... Barbara, Calif.) A new study by researchers from... Analysis and Synthesis (NCEAS) sheds light on how...ystems can be more effectively managed. , In a re...ors Kimberly A. Selkoe and Benjamin S. Halpern, bo...stern Hawaiian Islands (NWHI) a vast area stretch...
Other Biology News:Innerscope Research(R) Receives Three Great Minds Innovation Awards from the Advertising Research Foundation 2Ambati study published in PNAS 2Ambati study published in PNAS 3The fragility of the world's coral is revealed through a study of the Northwestern Hawaiian Islands 2The fragility of the world's coral is revealed through a study of the Northwestern Hawaiian Islands 3
...designed to allow neomycin/kanamycin selection in ...-neo-FRT template encodes the neomycin/kanamycin r...er (gb2) for expression of kanamycin resistance in...ression of neomycin resistance in mammalian cells....
CORNING CELLSTACK CAP, 33MM, PHENOL from Sigma-Aldrich
...es silica- binding technology with the convenience...of interest are extracted from slices of an agaros...ion Solution can dissolve an agarose gel slice fro...DNA fragments selectively adsorb onto the silica m...
...re designed for the rapid purification of linear 1... is excised from an,agarose gel and loaded into th...umn are a series of membranes and filters that hol...o selectively pass through the column into a colle...
Biology Products: